Switch to: Citations

Add references

You must login to add references.
  1. Law and policy in the era of reproductive genetics.T. Caulfield - 2004 - Journal of Medical Ethics 30 (4):414-417.
    The extent to which society utilises the law to enforce its moral judgments remains a dominant issue in this era of embryonic stem cell research, preimplantation genetic diagnosis, and human reproductive cloning. Balancing the potential health benefits and diverse moral values of society can be a tremendous challenge. In this context, governments often adopt legislative bans and prohibitions and rely on the inflexible and often inappropriate tool of criminal law. Legal prohibitions in the field of reproductive genetics are not likely (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  • The Commercialization of Human Stem Cells: Ethical and Policy Issues. [REVIEW]David B. Resnik - 2002 - Health Care Analysis 10 (2):127-154.
    The first stage of the human embryonic stem(ES) cell research debate revolved aroundfundamental questions, such as whether theresearch should be done at all, what types ofresearch may be done, who should do theresearch, and how the research should befunded. Now that some of these questions arebeing answered, we are beginning to see thenext stage of the debate: the battle forproperty rights relating to human ES cells. The reason why property rights will be a keyissue in this debate is simple and (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   17 citations  
  • A Pluralistic Account of Intellectual Property.D. B. Resnik - 2003 - Journal of Business Ethics 46 (4):319-335.
    This essay reviews six different approaches to intellectual property. It and argues that none of these accounts provide an adequate justification of intellectual property laws and policies because (1) there are many different types of intellectual property, and (2) a variety of incommensurable values play a role in the justification of intellectual property. The best approach to intellectual property is to assess and balance competing moral values in light of the particular facts and circumstances.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   23 citations  
  • Who “Owns” Cells and Tissues?Karen Lebacqz - 2001 - Health Care Analysis 9 (3):353-368.
    Opposition to `ownership' of cells and tissues often depends on arguments about the special or sacred nature of human bodies and other living things. Such arguments are not very helpful in dealing with the patenting of DNA fragments. Two arguments undergird support for patenting: the notion that an author has a `right' to an invention resulting from his/her labor, and the utilitarian argument that patents are needed to support medical inventiveness. The labor theory of ownership rights is subject to critique, (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Who “Owns” Cells and Tissues?Karen Lebacqz - 2001 - Health Care Analysis 9 (3):353-368.
    Opposition to `ownership' of cells and tissues often depends on arguments about the special or sacred nature of human bodies and other living things. Such arguments are not very helpful in dealing with the patenting of DNA fragments. Two arguments undergird support for patenting: the notion that an author has a `right' to an invention resulting from his/her labor, and the utilitarian argument that patents are needed to support medical inventiveness. The labor theory of ownership rights is subject to critique, (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974-1980.Sally Smith Hughes - 2001 - Isis 92 (3):541-575.
  • Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974-1980.Sally Hughes - 2001 - Isis 92:541-575.
    In 1973-1974 Stanley N. Cohen of Stanford and Herbert W. Boyer of the University of California, San Francisco, developed a laboratory process for joining and replicating DNA from different species. In 1974 Stanford and UC applied for a patent on the recombinant DNA process; the U.S. Patent Office granted it in 1980. This essay describes how the patenting procedure was shaped by the concurrent recombinant DNA controversy, tension over the commercialization of academic biology, governmental deliberations over the regulation of genetic (...)
    Direct download  
     
    Export citation  
     
    Bookmark   19 citations  
  • Patently controversial: Markets, morals, and the president's proposal for embryonic stem cell research.Joseph Fins & Madeleine Schachter - 2002 - Kennedy Institute of Ethics Journal 12 (3):265-278.
    : This essay considers the implications of President George W. Bush's proposal for human embryonic stem cell research. Through the perspective of patent law, privacy, and informed consent, we elucidate the ongoing controversy about the moral standing of human embryonic stem cells and their derivatives and consider how the inconsistencies in the president's proposal will affect clinical practice and research.
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • The unexamined assumptions of intellectual property.E. Richard Gold, Wen Adams, David Castle, Ghislaine Cleret De Langavant, L. Martin Cloutier, Abdallah S. Daar, Amy Glass, Pamela J. Smith & Louise Bernier - 2004 - Public Affairs Quarterly 18 (4):299-344.
  • Justifying intellectual property.Edwin C. Hettinger - 1989 - Philosophy and Public Affairs 18 (1):31-52.
  • Can Patents Deter Innovation?Michael Heller & Rebecca Eisenberg - 1998 - Science 280:698-701.
     
    Export citation  
     
    Bookmark   72 citations